« PreviousNext »Journal of the American Academy of Dermatology
Volume 60, Issue 1 , Pages 154-157, January 2009
Volume 60, Issue 1 , Pages 154-157, January 2009
Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin
Erlotinib, a specific epidermal growth factor receptor tyrosine kinase inhibitor, is used to treat various metastatic cancers. It is known to cause an acneiform rash. Herein, we report a case where the rash spared the previous radiotherapy field. A limitation of this study is that it is an anecdotal case report. Further research into the pathologic process of the rash is warranted to understand the reason for its absence in the irradiated skin.
Funding sources: None.
Conflicts of interest: None declared.
Reprints not available from authors.
PII: S0190-9622(08)01015-3
doi:10.1016/j.jaad.2008.07.057
© 2008 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
« PreviousNext »Journal of the American Academy of Dermatology
Volume 60, Issue 1 , Pages 154-157, January 2009
Volume 60, Issue 1 , Pages 154-157, January 2009

